CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is 6.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $367,000 | -10.7% | 89,400 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $411,000 | -4.6% | 94,800 | +11.0% | 0.00% | -20.0% |
| Q1 2021 | $431,000 | +643.1% | 85,400 | +532.6% | 0.01% | +400.0% |
| Q3 2020 | $58,000 | -94.3% | 13,500 | -92.3% | 0.00% | -92.9% |
| Q2 2020 | $1,022,000 | +73.5% | 174,286 | +245.1% | 0.01% | -56.2% |
| Q2 2018 | $589,000 | -15.0% | 50,500 | +87.9% | 0.03% | -38.5% |
| Q1 2018 | $693,000 | – | 26,871 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |